Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Clinical Medicine Research|January 17, 2017
Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With HypertensionYuhei Shiga, Shin-Ichiro Miura, Kota Motozato, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 20, 2012
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertensionYuhei Shiga, Shin-ichiro Miura, Ryoko Mitsutake, et al.International Heart Journal|May 13, 2017
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential HypertensionYuhei Shiga, Shin-Ichiro Miura, Kota Motozato, et al.Heart and Vessels|November 9, 2018
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE StudySatoshi Imaizumi, Yuhei Shiga, Masahiro Ogawa, et al.Heart and Vessels|April 12, 2019
Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE StudySatoshi Imaizumi, Yuhei Shiga, Masahiro Ogawa, et al.Pageof 3